Literature DB >> 16014544

Determination of ANA specificity using the UltraPlex platform.

Jodie Smith1, David Onley, Caroline Garey, Stuart Crowther, Nicholas Cahir, Adam Johanson, Sianie Painter, Grant Harradence, Ricardo Davis, Peter Swarbrick.   

Abstract

SmartBead Technologies has developed a multiplexed immunofluorescence assay, the UltraPlex ANA Profile, which determines nine antinuclear antibodies simultaneously. The UltraPlex assay platform uses bar-coded microparticles to track analytes through assays. These bar-coded microparticles were used to tag and track key ANA markers: Jo-1, Scl-70, Sm, SmRNP, SSA, SSB, U1RNP, Centromere B, dsDNA, and a blank control microparticle. The immunofluorescence assays are fully automated and are performed on a Perkin-Elmer multiprobe II liquid handling system that performs all sera dilutions, additions of reagents, washes, and incubation steps. Results were determined by the automated UltraPlex plate reader. This fully automated multiplex antinuclear antibody (ANA) immunoassay was used to screen commercially available ANA-positive sera and negative control samples. The UltraPlex ANA Profile enables the panels of samples to be screened simultaneously for nine ANA antoantibodies, requiring significantly less labor and fewer reagents, with performance equivalent to existing gold-standard methods.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16014544     DOI: 10.1196/annals.1313.030

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  10 in total

1.  A fully automated IIF system for the detection of antinuclear antibodies and antineutrophil cytoplasmic antibodies.

Authors:  O Shovman; N Agmon-Levin; B Gilburd; T Martins; A Petzold; T Matthias; Y Shoenfeld
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  The burden of the variability introduced by the HEp-2 assay kit and the CAD system in ANA indirect immunofluorescence test.

Authors:  M Infantino; F Meacci; V Grossi; M Manfredi; M Benucci; M Merone; P Soda
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

3.  A novel automated indirect immunofluorescence autoantibody evaluation.

Authors:  Shaye Kivity; Boris Gilburd; Nancy Agmon-Levin; Marina Garcia Carrasco; Yaron Tzafrir; Yael Sofer; Matilda Mandel; Thomas Buttner; Dirk Roggenbuck; Marco Matucci-Cerinic; Katalin Danko; Marcos López Hoyos; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2011-11-05       Impact factor: 2.980

Review 4.  Development and deployment of antigen arrays for investigation of B-cell fine specificity in autoimmune disease.

Authors:  Jeremy Sokolove; Tamsin M Lindstrom; William H Robinson
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

5.  MassCode liquid arrays as a tool for multiplexed high-throughput genetic profiling.

Authors:  Gregory S Richmond; Htet Khine; Tina T Zhou; Daniel E Ryan; Tony Brand; Mary T McBride; Kevin Killeen
Journal:  PLoS One       Date:  2011-04-22       Impact factor: 3.240

Review 6.  Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies.

Authors:  Michael Mahler; Pier-Luigi Meroni; Xavier Bossuyt; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-27       Impact factor: 4.818

Review 7.  Emerging technologies in autoantibody testing for rheumatic diseases.

Authors:  Nancy J Olsen; May Y Choi; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2017-07-24       Impact factor: 5.156

Review 8.  Synergism between particle-based multiplexing and microfluidics technologies may bring diagnostics closer to the patient.

Authors:  S Derveaux; B G Stubbe; K Braeckmans; C Roelant; K Sato; J Demeester; S C De Smedt
Journal:  Anal Bioanal Chem       Date:  2008-05-06       Impact factor: 4.142

9.  Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited.

Authors:  Yashwant Kumar; Alka Bhatia; Ranjana Walker Minz
Journal:  Diagn Pathol       Date:  2009-01-02       Impact factor: 2.644

10.  Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus.

Authors:  Michael Mahler; Aderajew Waka; F Hiepe; Marvin J Fritzler
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.